The US Food and Drug Administration has unveiled FDA PreCheck, a two-stage program designed to make it faster and more predictable for pharmaceutical companies to build and operate drug manufacturing plants in America.
The move comes as more than half of all medicines sold in the country are produced abroad,
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day